{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[381 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[114 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[43 (11), 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[382 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[115 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[73 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[44 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[26 (7), 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "As-randomized",
                    "n": "382"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[17 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, HIV VL]",
                "outcomes": "[330 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, HIV VL]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, HIV VL]",
                "outcomes": "[65 (20), 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, HIV VL]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, HIV VL]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, HIV VL]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[HIV detection visit, CD4]",
                "outcomes": "[331 (100), 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M3, CD4]",
                "outcomes": "[99 (30), 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M6, CD4]",
                "outcomes": "[64 (19), 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M9, CD4]",
                "outcomes": "[40 (12), 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M12, CD4]",
                "outcomes": "[25 (8), 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "study type": "HIV Seroconverter",
                    "analysis": "Summary of HIV Seroconverter Data",
                    "data type": "Available by Months Since HIV Detection Visit",
                    "exclusion criteria": "women infected at baseline and visits following ART initiation",
                    "group": "Continuous use",
                    "n": "331"
                },
                "measures": "[M15, CD4]",
                "outcomes": "[14 (4), 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 24,
    "total_ground_truth_claims": 30,
    "number_of_matches": 0
}